ID1 and prostate carcinoma: Moreover, Id1 has been shown to mediate chemotherapy resistance in hormone-independent prostate cancer cells [9,10] and ERK activation, and JNK and p38MAPK inhibition by Id1 in those cells has been suggested to be responsible for that resistance [9,10].